Navigating the Impact of the Inflation Reduction Act: A Guide for Small Molecule-Focused CDMOs – pharmaphorum

TL/DR –

The article discusses how Contract Development and Manufacturing Organizations (CDMOs) that focus on small molecules can navigate the impact of the Inflation Reduction Act. The Act aims to control inflation in the pharmaceutical industry, which can result in price hikes for CDMOs. The article suggests that CDMOs can manage this by focusing on operational efficiency, cost-saving technologies, and strategic collaboration.

Impact of the Inflation Reduction Act on Small Molecule-Focused CDMOs: A Guide to Navigation

Small molecule-focused Contract Development and Manufacturing Organizations (CDMOs) have been significantly impacted by the Inflation Reduction Act. This article provides strategic insights on how these organizations can effectively navigate these changes.

Read More US Economic News